This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06831/identifier/chemspider/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB06831/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06831/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06831/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB06831/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06831
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB06831 n14:DB06831
dcterms:title
2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE
adms:identifier
n9:99443302 n10:039 n11:6852165 n12:5254620 n13:DB06831
n3:IUPAC-Name
n4:271B5611-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5617-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5616-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5613-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5614-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5615-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B560F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B560D-363D-11E5-9242-09173F13E4C5 n4:271B5610-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B560E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B561D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B561E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5618-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5619-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B561B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B561A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B561C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5623-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5625-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5626-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5622-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5621-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5624-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5612-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B561F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5620-363D-11E5-9242-09173F13E4C5